Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
07/1998
07/16/1998WO1998030241A1 Methods of therapeutic administration of anti-cd40l compounds
07/16/1998WO1998030240A1 Treatment of lupus nephritis with anti-cd40l compounds
07/16/1998WO1998030239A2 Process for preparing conjugate vaccines including free protein and the conjugate vaccines, immunogens, and immunogenic reagents produced by this procedure
07/16/1998WO1998030238A1 Methods and compositions for screening of human borna disease virus
07/16/1998WO1998030236A1 Biological pesticide
07/16/1998WO1998030235A1 Lactoferrin tablets
07/16/1998WO1998030234A1 Compositions for osteogenesis and chondrogenesis
07/16/1998WO1998030233A1 Pharmaceutical compositions for the treatment of the eye
07/16/1998WO1998030232A1 Methods and compositions for preventing autoimmune disease
07/16/1998WO1998030231A1 Use of exendins and agonists thereof for the reduction of food intake
07/16/1998WO1998030230A1 Protein-containing compositions and process for producing the same
07/16/1998WO1998030229A1 TREATMENTS FOR NEUROTOXICITY IN ALZHEIMER'S DISEASE BY β-AMYLOID PEPTIDES
07/16/1998WO1998030228A1 Compounds and their combinations for the treatment of influenza infection
07/16/1998WO1998030227A1 Treatment of multiple sclerosis through ingestion or inhalation of copolymer-1
07/16/1998WO1998030225A1 Preparation of collagen
07/16/1998WO1998030216A1 Use of angiotensin ii antagonists to treat symptomatic heart failure
07/16/1998WO1998030211A1 Dosage composition for nasal delivery and method of use of the same
07/16/1998WO1998030204A1 Pharmaceutical microemulsion preconcentrates comprising cyclosporins
07/16/1998WO1998030147A1 Composition containing a radioactive component for treatment of vessel wall
07/16/1998WO1998030101A1 Gene therapy approaches to target cell death for cancer treatment: compositions and methods
07/16/1998WO1998024463A3 Combination therapy using a tnf binding protein for treating tnf-mediated diseases
07/16/1998WO1998023752A3 Papilloma viruses, agents for detecting the same and for treating diseases caused by such viruses
07/16/1998WO1998023638A3 Complement inhibitor
07/16/1998WO1998022586A3 HUMAN POLYHOMEOTIC 2 (hph2) ACTS AS A TUMOR SUPPRESSOR
07/16/1998WO1998022496A3 Antiviral peptide derivatives
07/16/1998WO1998020028A3 Clavanins
07/16/1998WO1998019697A3 Novel pharmaceutical compositions
07/16/1998WO1998019674A3 A method for treating tension-type headache
07/16/1998WO1998018822A3 Novel human lim proteins
07/16/1998WO1998017804A3 A HELICOBACTER ANTIGEN (η-GLUTAMYLTRANSFERASE) AND SEQUENCES ENCODING THE SAME
07/16/1998WO1998014576A3 Secreted proteins and polynucleotides encoding them
07/16/1998WO1998014567A3 Methods and compositions for inhibiting bacterial growth
07/16/1998WO1998011220A3 Novel human cell division cycle proteins
07/16/1998WO1997035881A3 Receptor and transporter antagonists
07/16/1998CA2278344A1 Recombinant human iga-j. chain dimer
07/16/1998CA2278330A1 Composition containing a radioactive component for treatment of vessel wall
07/16/1998CA2278326A1 Eukaryotic gene expression cassette and uses thereof
07/16/1998CA2278104A1 Secreted proteins and polynucleotides encoding them
07/16/1998CA2278001A1 Csk homologous kinase (chk) for detecting and treating breast cancer
07/16/1998CA2277944A1 Non-immunogenic prodrugs and selectable markers for use in gene therapy
07/16/1998CA2277880A1 Use of pea3 in tumor suppression
07/16/1998CA2277778A1 Specific pancreatic lipase inhibitors and their applications
07/16/1998CA2277582A1 Compounds, compositions and methods for the endocytic presentation of immunosuppressive factors
07/16/1998CA2277519A1 Treatments for neurotoxicity in alzheimer's disease by .beta.-amyloid peptides
07/16/1998CA2277223A1 Methods of therapeutic administration of anti-cd40l compounds
07/16/1998CA2277222A1 Treatment of lupus nephritis with anti-cd40l compounds
07/16/1998CA2277121A1 Macrocyclic inhibitors of matrix metalloproteinases and tnf.alpha. secretion
07/16/1998CA2277084A1 Human chloride channel protein (hccp)
07/16/1998CA2277034A1 Complexes and combinations of fetuin with therapeutic agents
07/16/1998CA2276533A1 Human endosulfine gene
07/16/1998CA2276088A1 Secreted proteins and polynucleotides encoding them
07/16/1998CA2276085A1 Secreted proteins and polynucleotides encoding them
07/16/1998CA2276063A1 Secreted proteins and polynucleotides encoding them
07/16/1998CA2276046A1 Novel epithelial tissue targeting agent
07/16/1998CA2274731A1 Myelopeptides and their therapeutic use
07/16/1998CA2267106A1 Novel hedgehog-derived polypeptides
07/15/1998EP0853126A2 cDNA clone HE8CS41 that encodes a human 7-transmembrane receptor
07/15/1998EP0853125A2 cDNA clone HNFJD15 that encodes a human 7-transmembrane receptor
07/15/1998EP0853121A2 Human DNase
07/15/1998EP0852951A1 Stable lyophilized monoclonal or polyclonal antibodies containing pharmaceuticals
07/15/1998EP0852946A2 Composition for cosmetic, pharmaceutical or dietetic use based on an amino-sugar and/or a polyhydroxylic acid
07/15/1998EP0852913A1 Composition and method for treatment of inflammatory conditions of the gastro-intestinal tract
07/15/1998EP0852627A1 Cell death protein
07/15/1998EP0852624A2 Glycoprotein b of the rfhv/kshv subfamily of herpes viruses
07/15/1998EP0852619A1 A modified glutamic acid decarboxylase (gad)
07/15/1998EP0852618A1 Autologous immune cell therapy: cell compositions, methods and applications to treatment of human disease
07/15/1998EP0852587A2 Synthetic peptides that inhibit il-6 activity
07/15/1998EP0852586A1 Binding protein
07/15/1998EP0852585A1 Method for treating alzheimer's disease using glial cell line-derived neurotrophic factor (gdnf) protein product
07/15/1998EP0852584A1 Peptide derivatives having endothelin receptor antagonistic activity
07/15/1998EP0852504A1 Inhibitors of integrin receptors and their therapeutical uses
07/15/1998EP0852502A1 Lantibiotic mutants and chimeras of enhanced stability and activity
07/15/1998EP0852494A2 Peripherally active anti-hyperalgesic opiates
07/15/1998EP0852493A1 Transdermal matrix system
07/15/1998EP0852492A1 Transdermal matrix system
07/15/1998EP0852491A1 Use of heparinases to decrease inflammatory responses
07/15/1998EP0852490A2 Emulsion and micellar formulations for the delivery of biologically active substances to cells
07/15/1998EP0852469A2 Use of threonine for the treatment of phenylketonuria
07/15/1998EP0692032A4 Suppressor of hiv replication and transcription
07/15/1998EP0681477A4 Genetic modification of neural stem cells.
07/15/1998EP0675736B1 Improved synthesis of polymer bio-active conjugates
07/15/1998EP0648224B1 Conformationally restrained peptide analogs as antiplatelet agents
07/15/1998EP0551329B1 Aprotinin analogues
07/15/1998EP0528926B1 Soluble peptide analogues containing binding sites
07/15/1998EP0218717B1 Recombinant inhibin
07/15/1998CN1187824A Novel protein and process for producing same
07/15/1998CN1187774A CNS neurite out growth modulators, and compositions, cells and methods embodying and using same
07/15/1998CN1187773A Method for treatment of pain
07/15/1998CN1187772A Method of preventing or treating allergies
07/15/1998CN1187771A Use of nitric oxide-releasing agents to treat imptotency
07/15/1998CN1187754A FGF9 as specific ligand for FGFR3
07/15/1998CN1187490A 5-membered ring heterocycles as inhibitors of leucocyte adhesion and as VLA-4 antagonists
07/15/1998CN1187368A Recombinant coccidiosis vaccines
07/15/1998CN1039126C Tachiquinine antagonist tricyclic compounds and pharmaceutical compositions containing such compounds
07/15/1998CN1039125C Amidinophenylalanine derivatives and process for preparing same and use
07/15/1998CN1039124C Partially modified and retro-inverted tetrapeptides analogues of c-reactive protein fragments and medicinal composition
07/15/1998CA2226803A1 Liquid gonadotropin containing formulations
07/14/1998US5780631 Anticoagluant
07/14/1998US5780615 Glycosylation of lipids and lipid-containing particles and diagnostic and therapeutic methods and materials derived therefrom
07/14/1998US5780612 Oligonucleotide antiproliferative agent
1 ... 2608 2609 2610 2611 2612 2613 2614 2615 2616 2617 2618 2619 2620 2621 2622 2623 2624 2625 2626 2627 2628 ... 3163